Please login to the form below

market

This page shows the latest market news and features for those working in and with pharma, biotech and healthcare.

Novo Nordisk announces positive phase 3 results for oral weight-loss drug

Semaglutide is already available in major markets as a once-weekly injection. ... Semaglutide is already available in major markets for weight management under the brand names Wegovy and Rybelsus as a once-weekly injection.

Latest news

AstraZeneca’s heart failure treatment recommended by NICE for expanded use

Forxiga, sold as Farxiga in certain markets, has previously been recommended by NICE as a treatment option for HF patients with reduced ejection fraction (HFrEF) which is equal to or less
WHO report shows gaps in pipeline of antibiotic treatments to combat AMR

Previous commitments reported in 2021 and 2022 were to act on AMR strategies and address antibiotic market failures, preserve effectiveness of essential existing antibiotics through economic conditions and ensure access, strengthen ... AMR research and
Bristol Myers Squibb’s Sotyktu approved by MHRA for plaque psoriasis

Sotyktu is already approved in major markets, including in the US and Japan.
Too much success

The ‘budget buster’. And some of the innovative new products reaching the market might indeed threaten our industry’s delicate arrangement with society. ... In today’s market, Wegovy and Lecanemab are early signs of such business models emerging.
Outsmarting unpredictability: using scenario planning to keep ahead

This helps you stay agile and adapt quickly as the market shifts.

More from news
Approximately 163 fully matching, plus 4,829 partially matching documents found.

Latest Intelligence

Using the power of data to future-proof the clinical development industry

With 28% of trials cancelled during phase 2 in 2022, there will be an inevitable reduction of new therapies reaching the market.
The impact of AI on digital health: the fifth industrial revolution

content. Machine learning, deep learning and natural language processing help democratise the analysis of data to create insights on how best to position a product in the market.
New beginnings – learning the language of change

market strategies, but Little believes the positive glow from vaccine success has presented a moment for industry to push further.
Why diagnostics investments are crucial to win the AMR battle

Too many new drug companies have gone bankrupt developing antibiotics for a market built on selling at scale rather at smaller volumes based on need. ... Diagnostic testing. As new drugs come to market, they need to be accompanied by a new generation of
Mind the gap: are digital health solutions really patient centric?

Global market research was recently conducted to understand the impact COVID-19 was having on patient management. ... Market research will give them the required insights to ensure that newly developed digital solutions and services are keeping the

More from intelligence
Approximately 91 fully matching, plus 745 partially matching documents found.

Latest appointments

Research Partnership announces new CEO Gareth Phillips

Phillips joins the company with a wealth of global experience, having spent 25 years in healthcare market research working with IMS Health – now IQVIA – and Synovate Healthcare, before it was acquired ... I have long admired Research Partnership as a
OPEN Health appoints Stephen Chick as chief growth officer for Evidence & Access

Chick will be responsible for leading the organisation’s business development plans in order to grow revenue and expand market share. ... as working with suppliers from the real-world evidence (RWE) and market access sectors.
Hanover appoints Ian Dodge to its senior adviser panel

With this appointment, Dodge joins a group of senior advisers for Hanover focused on market access and health system innovation including former payers, regulators, industry executives and health system managers in ... the UK, European and international
Four Communications Group appoints Sarah Hart as director of Four Health

Her time in the industry has reinforced her knowledge of supporting market access strategies and crisis management.
ZPB Associates appoints David Rowley as a Board adviser

With extensive experience in healthcare market access and strategy, in his new role, Rowley will support the growth of the business by driving its reach into the pharmaceutical sector through its ... expanded market access and insight offering.

More from appointments
Approximately 9 fully matching, plus 433 partially matching documents found.

Latest from PMHub

Medscape Medical Affairs Selected as Finalist for 2023 Communiqué Awards

Address:. WebMD Global, Kent House. 14-17 Market Place. London. United Kingdom.
Breaking the silence: It’s time to talk about the menopause

So, what does this mean for pharma and the healthcare market research industry? ... In addition, we have specialised Emerging Markets and Behavioural Science teams, who we work in collaboration with to help pharmaceutical clients fully understand the
MarketsResearch.biz

We have a leading market intelligence team which accredits and provides the reports of some of the top publishers in the field of the technology industry.
Maloff Mosquito

Product: Maloff Protect. Client: Glenmark Pharmaceuticals. Therapy area: OTC Products. View the PMHub profile for: .
Porterhouse Medical rewards superb client service skills

Porterhouse Medical is delighted to announce the promotion of Gema Noguera to senior account director. Since joining the client services team as a senior account executive in 2013, Gema has consistently demonstrated her superb client service skills